Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Nora M. Hagelberg |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Inhibition of cytochrome p450 3a by clarithromycin uniformly affects the pharmacokinetics and pharmacodynamics of oxycodone in young and elderly volunteers / Antti Liukas en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 3 (Junio)
[artículo]
Título : Inhibition of cytochrome p450 3a by clarithromycin uniformly affects the pharmacokinetics and pharmacodynamics of oxycodone in young and elderly volunteers Tipo de documento: texto impreso Autores: Antti Liukas, Autor ; Nora M. Hagelberg, Autor ; Kristiina Kuusniemi, Autor Fecha de publicación: 2022 Artículo en la página: pp. 302-308 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Oxicodona, Interacción, Claritromicina, CYP3A4 Resumen: The aim of this study was to investigate the effect of the cytochrome P450 3A4 inhibitor clarithromycin on the pharmacokinetics and pharmacodynamics of oral oxycodone in young and elderly subjects. Ten young and 10 elderly healthy subjects participated in this placebo-controlled, randomized, 2-phase crossover study. Link: ./index.php?lvl=notice_display&id=29377
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 3 (Junio) . - pp. 302-308[artículo] Inhibition of cytochrome p450 3a by clarithromycin uniformly affects the pharmacokinetics and pharmacodynamics of oxycodone in young and elderly volunteers [texto impreso] / Antti Liukas, Autor ; Nora M. Hagelberg, Autor ; Kristiina Kuusniemi, Autor . - 2022 . - pp. 302-308.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 3 (Junio) . - pp. 302-308
Palabras clave: Oxicodona, Interacción, Claritromicina, CYP3A4 Resumen: The aim of this study was to investigate the effect of the cytochrome P450 3A4 inhibitor clarithromycin on the pharmacokinetics and pharmacodynamics of oral oxycodone in young and elderly subjects. Ten young and 10 elderly healthy subjects participated in this placebo-controlled, randomized, 2-phase crossover study. Link: ./index.php?lvl=notice_display&id=29377